These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2896361)

  • 41. Is dynorphin a k ligand?
    Lee NM
    Proc West Pharmacol Soc; 1983; 26():309-11. PubMed ID: 6136981
    [No Abstract]   [Full Text] [Related]  

  • 42. Tritiated ethylketocyclazocine binding in rat brain: differential distribution of binding sites across brain regions.
    Hewlett WA; Akil H; Carlini W; Barchas JD
    Life Sci; 1982 Sep 20-27; 31(12-13):1351-4. PubMed ID: 6128657
    [No Abstract]   [Full Text] [Related]  

  • 43. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dynorphin: analgesic effect via kappa receptors in spinal cord of the spinal cords of rats].
    Xie GX; Han JS
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):231-4. PubMed ID: 6152645
    [No Abstract]   [Full Text] [Related]  

  • 46. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release.
    Mulder AH; Wardeh G; Hogenboom F; Frankhuyzen AL
    Nature; 1984 Mar 15-21; 308(5956):278-80. PubMed ID: 6322011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kappa opioid receptor-mediated analgesia in the developing rat.
    Barr GA; Paredes W; Erickson KL; Zukin RS
    Brain Res; 1986 Oct; 394(2):145-52. PubMed ID: 3021285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Learned food aversions: heterogeneity of animal models of tumor-induced anorexia.
    Bernstein IL; Fenner DP
    Appetite; 1983 Jun; 4(2):79-86. PubMed ID: 6578702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of the endogenous opiates in zinc deficiency anorexia.
    Essatara MB; Morley JE; Levine AS; Elson MK; Shafer RB; McClain CJ
    Physiol Behav; 1984 Mar; 32(3):475-8. PubMed ID: 6146993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
    Pesce GO; Lang MA; Cruciani RA; Russell JT; Gainer H; Rodbard D
    NIDA Res Monogr; 1986; 75():77-80. PubMed ID: 2893283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
    Martinka GP; Jhamandas K; Sabourin L; Lapierre C; Lemaire S
    Eur J Pharmacol; 1991 Apr; 196(2):161-7. PubMed ID: 1678718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Traumatic injury alters opiate receptor binding in rat spinal cord.
    Krumins SA; Faden AI
    Ann Neurol; 1986 May; 19(5):498-501. PubMed ID: 3013077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of opiate agonists on day-night feeding rhythms in young and old mice.
    Kavaliers M; Hirst M
    Brain Res; 1985 Feb; 326(1):160-7. PubMed ID: 2982458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Walker carcinoma 256: a model for studies on tumor-induced anorexia and cachexia.
    Guaitani A; Recchia M; Carli M; Rocchetti M; Bartosek I; Garattini S
    Oncology; 1982; 39(3):173-8. PubMed ID: 6952138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Presence of dynorphin-like immunoreactivity but not opiate binding in Walker-256 tumors.
    Bryant HU; Conroy WG; Isom GE; Malven PV; Yim GK
    Life Sci; 1985 Jul; 37(2):155-60. PubMed ID: 2861551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of kappa opioid receptors in the rabbit ear artery.
    Berzetei IP; Fong A; Yamamura HI; Duckles SP
    Eur J Pharmacol; 1988 Jul; 151(3):449-55. PubMed ID: 2905660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B; Rajpara A; O'Connor LH; Cicero TJ
    Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T; Shoemaker WJ
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A kappa-selective opioidergic pathway is involved in the reversal of a behavioural effect of adrenalectomy.
    Jefferys D; Boublik J; Funder JW
    Eur J Pharmacol; 1985 Jan; 107(3):331-5. PubMed ID: 2984011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.